A retrospective study to determine efficacy, tolerability and pharmacokinetic variability of Brivaracetam among adult patients with difficult-to-treat epilepsy
Latest Information Update: 20 Jun 2022
At a glance
- Drugs Brivaracetam (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
Most Recent Events
- 01 Jul 2022 Results published in the Epilepsy Research
- 20 Jun 2022 New trial record